| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K51490254 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |